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The Escherichia coli methionine ABC transporter MetNI exhibits
both high-affinity transport toward L-methionine and broad spec-
ificity toward methionine derivatives, including D-methionine.
In this work, we characterize the transport of D-methionine de-
rivatives by the MetNI transporter. Unexpectedly, the N229A
substrate-binding deficient variant of the cognate binding protein
MetQ was found to support high MetNI transport activity toward
D-selenomethionine. We determined the crystal structure at 2.95 Å
resolution of the ATPγS-bound MetNIQ complex in the outward-
facing conformation with the N229A apo MetQ variant. This struc-
ture revealed conformational changes in MetQ providing sub-
strate access through the binding protein to the transmembrane
translocation pathway. MetQ likely mediates uptake of methionine
derivatives through two mechanisms: in the methionine-bound
form delivering substrate from the periplasm to the transporter
(the canonical mechanism) and in the apo form by facilitating ligand
binding when complexed to the transporter (the noncanonical
mechanism). This dual role for substrate-binding proteins is pro-
posed to provide a kinetic strategy for ABC transporters to transport
both high- and low-affinity substrates present in a physiological
concentration range.
ATP Binding Cassette transporter | alternating access transport
mechanism | methionine transporter | transinhibition
The substrate specificity of a transporter represents one of themost basic functional attributes and often serves as the de-
fining characteristic. Transporters can exhibit both high affinity
for a particular substrate and broad specificity in translocating
related compounds. An example is the Escherichia coli MetNI
methionine importer established by Kadner et al. to mediate the
high-affinity uptake of L-methionine, while transporting D-me-
thionine with lower affinity; other methionine derivatives in-
cluding selenomethionine are also transported (1–4). MetNI is a
member of the ATP Binding Cassette (ABC) family of trans-
porters (5–9), consisting of two transmembrane subunits (MetI)
that form a translocation pathway and two nucleotide-binding
subunits (MetN) that couple ATP binding and hydrolysis to
transport (10, 11). As for other ABC importers (5, 12–15),
MetNI requires an additional component, MetQ (8, 10, 11, 16–
18), which is a substrate-binding protein (SBP), generally viewed
to deliver substrates to their cognate transporters.
The role of SBPs has been intriguing since their original
identification as osmotic sensitive components that were re-
quired for the transport of certain nutrients (19). Investigations
of a number of SBPs support a model where binding of substrate
by free apo-SBP is accompanied by a “Venus flytrap” confor-
mational change (20, 21), followed by delivery of ligand to the
ABC transporter (22–25); in this canonical model, the SBP de-
livers the substrate to the transporter and is predominantly re-
sponsible for the substrate specificity of transport. However,
these sequential events have been challenged by biochemical and
single-molecule studies (26–30), including an early demonstra-
tion by Shuman that binding protein-independent variants of the
MalFGK2 maltose transporter could be isolated (31, 32). Dif-
ferent roles of the binding protein were also inferred by Merino
and Shuman (33), who reported that the unliganded maltose-
binding protein, despite its inability to bind lactose, is required
for a MalFGK2 variant to transport lactose efficiently. The
properties of these variants suggested substrate specificity was
determined in the transmembrane regions of the transporter
itself (31, 34). Participation of both the SBP and the transporter
in determining substrate specificity was reported in a structural
analysis of the maltose transporter with various bound substrates
(35). More recently, studies have suggested a role for substrates
binding directly to a preformed complex between the SBP and
transporter, rather than delivered to the transporter by free SBP
(28, 30).
Although these studies have provided evidence for a non-
canonical role of SBPs in facilitating substrate uptake by ABC
importers, no supporting structural evidence has been reported.
Significance
The high-affinity methionine importer MetNI belongs to the
ATP Binding Cassette (ABC) family of transporters that carry
out the ATP-dependent uptake of substrates into cells. As with
other ABC importers, MetNI requires a soluble binding protein
(MetQ) that in the canonical mechanistic model delivers sub-
strates to the transporter. We made the unexpected observa-
tion that a MetQ variant with significantly impaired ligand-
binding properties supports D-selenomethionine uptake at a
higher rate than wild-type MetQ. A crystal structure of MetNIQ
in the outward-facing conformation reveals access channels
through the binding protein to the transmembrane trans-
location pathway. These studies support a noncanonical role
for the binding protein in facilitating the uptake of cer-
tain substrates directly through the transporter–binding
protein complex.
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In the course of characterizing the transport properties of
MetNI, we made an unexpected observation that the N229A
MetQ variant with greatly reduced ligand binding affinity
supported D-selenomethionine uptake at a higher rate than
wild-type MetQ. We solved a crystal structure of the ATPγS-
bound MetNI in complex with the ligand free N229A variant of
MetQ. This structure reveals unprecedented features of the
outward-facing conformation that support a noncanonical trans-
port mode of the MetNI transporter in which MetQ facilitates
access of substrate to the translocation pathway through the
MetNIQ complex. The ability of intracellular methionine to in-
hibit the uptake of extracellular methionine (transinhibition), a
key component of MetNI regulation described by Kadner (3), is
also structurally detailed.
Unexpected High Transport Rates for a Substrate-Binding
Deficient MetQ
To address the transport function of MetNI, we carried out in
vivo transport assays using a ΔmetNIQ knockout E. coli strain.
There are two transport systems in E. coli that are responsible for
methionine uptake (4): the higher-affinity MetD transport
system (MetNIQ operon) and the lower-affinity, and as yet
uncharacterized, MetP system (36). The uptake of L-methionine
is mediated by both systems, whereas D-methionine is specifically
transported by MetD (2, 4, 36). To selectively study MetNI
transport, we took advantage of the exclusive role of MetNI in D-
methionine transport and used a D-methionine derivative, D-
selenomethionine (D-semet), as the transport substrate for
quantification by inductively coupled plasma-mass spectrometry
(ICP-MS) (Fig. 1A). Kinetic constants for the transport activity
of D-semet derived from Michaelis–Menten analysis (Fig. 1B)
are shown in Table 1. The maximal uptake rate of the wild-type
MetNIQ is 6.3 ± 0.4 nmol·min−1·mg−1 of transporter, with Km =
1.8 μM (n = 3) (Fig. 1B and Table 1). Because L-methionine
is present in the cytoplasm at 0.1–0.3 mM (1, 37), to bypass
the potential transinhibition effect, an N295A mutation at the
C2 domain of the MetNI was introduced that reduced the
binding of L-methionine to undetectable levels as assessed by
isothermal titration calorimetry (ITC). This variant results in a
higher maximal uptake rate of 10 ± 0.5 nmol·min−1·mg−1 of
transporter (n = 9) with no change in Km (Fig. 1B and Table 1).
We infer this represents the uptake rate of D-methionine by
MetNI in the absence of transinhibition regulation by the in-
ternal pool of L-methionine.
Deletion of MetQ significantly reduced the uptake rate of D-
semet to 0.2 ± 0.1 nmol·min−1·mg−1 of transporter (n = 3), which
indicates that MetQ is required for the transport; however, an
unanswered question is whether MetQ must bind substrate and
deliver it to the transporter. To address this question, we gen-
erated a substrate-binding deficient variant of MetQ, N229A
(NA MetQ), that reduces the affinity of MetQ for D-methionine
by ∼20-fold and for D-semet by approximately eightfold compared
with the wild-type MetQ (SI Appendix, Fig. S1). Unexpectedly, the
N229AMetNIQ mutation stimulates the maximal transport rate for
D-semet (Vmax = 10.5 ± 0.9 nmol·min
−1·mg−1 of transporter) (n = 6)
by ∼1.5-fold compared with the wild-type MetNIQ (Vmax = 6.3 ±
0.4 nmol·min−1·mg−1 of transporter), with an approximately four-
fold increase in Km to 7.4 μM (Fig. 1B and Table 1). A similar
stimulation is observed for the MetQ N229A variant in combination
with the MetN N295AMetNIQ (Vmax = 15.4 ± 1.3 nmol·min
−1·mg−1
of transporter) (n = 6) compared with the MetN N295A MetNIQ
(Vmax = 10 ± 0.5 nmol·min
−1·mg−1 of transporter) (Fig. 1B and
Table 1). These results indicate that the binding protein can
facilitate substrate uptake through mechanisms in addition to
the canonical role where the free SBP delivers the substrate to
the transporter.
Conformational Changes in the Outward-Facing State
To complement our functional data, we determined the 2.95-Å
resolution crystal structure of the ATPγS-bound E166Q N295A
MetNI in complex with N229A MetQ (Fig. 2A). As anticipated,
MetNI adopts an outward-facing (OWF) conformation exhibit-
ing significant conformational changes relative to the uncom-
plexed MetNI in the inward-facing (IWF) state (Fig. 2 B–D). A
convenient reference frame is the molecular twofold axis that
relates the pairs of MetNI subunits in each conformation. Rel-
ative to the IWF conformation, the MetI subunits in the MetNIQ
complex have rotated ∼31° toward the molecular twofold axis (SI
Appendix, Fig. S2) opening the translocation pathway toward
the periplasm and closing it at the cytoplasm. Relative to the
transmembrane domains, the nucleotide binding domains
(NBDs) are rotated ∼18° toward the molecular twofold axis in
going from the IWF to OWF conformation, facilitating di-
merization of two NBDs in the presence of ATPγS.
Fig. 1. In vivo uptake assay of MetNIQ and its variants. (A) Schematic of
whole-cell uptake assay for MetNIQ variants. (B) Michaelis–Menten plot
of initial velocities for D-semet uptake versus substrate concentrations
for MetNIQ and its variants. The corresponding Vmax and Km values are
listed in Table 1.
Table 1. Summary of kinetic constants for transport activity of
MetNIQ variants
MetNIQ variants Uptake rate Vmax* Km, μM
MetNIQ 6.3 ± 0.4 1.8 ± 0.4
MetNI 0.2 ± 0.1 N/A
N295A (EcN) MetNIQ 10 ± 0.5 1.7 ± 0.3
N229A (EcQ) MetNIQ 10.5 ± 0.9 7.4 ± 0.5
N295A, N229A MetNIQ 15.4 ± 1.3 4.8 ± 0.7
N295A, F103A (EcI) MetNIQ — —
N295A, M107A (EcI) MetNIQ — —
N295A, Y160A (EcI) MetNIQ 14.0 ± 1.3 4.1 ± 0.2
N295A, M163A (EcI) MetNIQ 4.7 ± 0.5 1.4 ± 0.2
The maximum uptake rate (Vmax) and Michaelis–Menten constant (Km)
were determined from the plot shown in Fig. 1B. N/A, not applicable; dash,
not detectable. The molar ratio of the MetQ:MetNI variants in these studies
was measured to be ∼4.
*nmol·min−1·mg−1 of transporter.
2 of 9 | www.pnas.org/cgi/doi/10.1073/pnas.1811003115 Nguyen et al.
MetNI-catalyzed transport is regulated by the intracellular con-
centration of methionine, a phenomenon known as transinhibition
(1–3), which is mediated by the C2 domains located at the
C-terminal end of the MetN subunits (8, 38, 39). Between the IWF
[Protein Data Bank (PDB) ID codes 3DHW, 3TUI, and 3TUZ]
and OWF conformations, the C2 domains rotate ∼32° around the
molecular twofold axis (SI Appendix, Fig. S2); this rearrangement is
associated with the binding of L-methionine across the interface
between C2 domains in the IWF conformation (SI Appendix, Fig.
S3A). The transition to the OWF conformation is accompanied by a
repositioning of the C2 domains arising from a register shift (38) in
the hydrogen-bonding network across the antiparallel β-sheet sta-
bilizing the C2 dimer (SI Appendix, Fig. S3B). The toggling of the
C2 dimer between these two states in the absence and presence of
methionine shifts the separation between the two H-motif catalytic
residues H199 from 13 to 24 Å (Cα to Cα), respectively. Although
H199 and the adjacent 200-helix (residues 200–205) are part of the
NBDs, each 200-helix maintains a fixed position with respect to a
single C2 subunit (Fig. 3). Consequently, the shift in β-sheet register
leads to a significantly increased separation between the H199
residues in the presence of methionine.
A Substrate Access Channel in the Outward-Facing State
Significant rearrangements are also evident in the conformation
of MetQ in the MetNIQ complex relative to the methionine-
bound form. In contrast to the Venus flytrap-type of hinge
bending motion that separates the two lobes of the MalE and
BtuF SBPs in complexes with MalFGK2 and BtuCD, re-
spectively, MetQ in the MetNIQ complex shows a 24° twist
around an axis perpendicular to the interface between the two
lobes (Fig. 4A). Significantly, this twisting motion creates an
opening for substrate access through MetQ that is not present in
the MalFGK2E and BtuCDF complexes. The rmsd between the
methionine-bound form of MetQ and the conformation of MetQ
in complex with MetNI is 4.4 Å, which, despite the smaller ligand
size, is larger than observed between the corresponding liganded
and transporter-bound forms for MalE (40) and BtuF (41, 42)
with rmsds of 3.2 and 1.0 Å, respectively. The outward hinge-type
movements of the MalE and BtuF SBP lobes, together with in-
sertions of periplasmic or scoop loops from the transmem-
brane subunits (Fig. 5A), have been proposed to facilitate
substrate delivery from the SBP to the maltose and vitamin
B12 transporters (22, 41). In contrast, scoop loops are not pre-
sent in the MetNIQ complex (Fig. 5A). The combination of the
large distortion of MetQ upon complex formation with MetNI
and the relatively small size of the methionine substrate may
allow exogenous methionine to access the MetNIQ complex
through MetQ. To explore this possibility, the CAVER 3.0.1
program (43) was used to identify several possible substrate entry
pathways in MetNIQ, using a shell radius of 3 Å. Identifi-
cation of a continuous channel starting at the cleft between
the two lobes of the complexed MetQ suggests that methio-
nine cannot only access the MetQ substrate binding site but
can also reach the translocation pathway through MetI in the
MetNIQ complex (Fig. 4B). This structure therefore provides
evidence for a substrate entry pathway in an ABC importer–
SBP complex through the SBP.
Gating Mechanisms
Interconversion of the inward- and outward-facing conforma-
tions of MetNI is associated with rearrangements of the cyto-
plasmic and periplasmic gates (Fig. 6). At the periplasmic gate,
residues Y177 and M163 move away from the center of the
translocation pathway (Fig. 6A), compared with those in the IWF
conformation of MetNI (Fig. 6B). On the other side, gating resi-
due M107 (TM3) from both MetI subunits form a cytoplasmic
gate, not seen in the IWF conformation of MetNI (Fig. 6D),
restricting the translocation pathway (Fig. 6C). Although sub-
stitution of the periplasmic gate M163 to A reduces maximal
transport activity (Vm= 4.7 ± 0.5 nmol·min
−1·mg−1 of transporter)
Fig. 2. Crystal structure of the MetNIQ complex. (A) Side-view representa-
tion of the MetNIQ. MetQ subunit is colored slate, MetI subunits are forest
and pale yellow, and MetN subunits are cyan and firebrick. C-regulatory (C2)
domains are at the C termini of MetN subunits. Conformational changes of
(B) the transmembrane MetI subunits, (C) the nucleotide-binding MetN
subunits, and (D) the C2 domains between their OWF (colored as described
in A) and IWF conformations (PDB ID code 3TUJ) (colored gray). One subunit
of MetI (colored forest) or MetN (colored cyan) of the OWF conformation
was overlaid to that of the IWF conformation to highlight the differences in
the relative placement of the opposite subunit (B and C). Superposition of
MetNIQ and MetNI reveals the rotation of the C2 domains around the mo-
lecular twofold axis between the two structures (D).
Fig. 3. Rotation of the C2 domains facilitates ATP-induced dimerization of
MetN subunits. Comparison of the C2 domains following superposition of
one of the two C2 domain subunits. C2 domains are presented in the locked
transinhibited IWF state (colored wheat; PDB ID code 3TUZ), the unlocked
IWF state (colored light blue; PDB ID code 3TUJ), and MetNIQ in the OWF
state [colored firebrick, structure 3; PDB ID code 6CVL (this study)]. The
superimposed subunit is to the right in each panel. This comparison high-
lights the significant differences in the two subunits between these states.
Of note, the separation between the 200-helices (cyan ellipses, Left) in the
unlocked OWF MetNIQ (NIQ) and IWF DM states is significantly shorter than
in the IWF locked state (CY5) in the presence of methionine. As a conse-
quence, the catalytic H-motif H199 residues from both NBDs are too far
apart in the locked state to form the ATPase active form of the NBDs. L-
methionine bound to the regulatory sites on the C2 domains are depicted as
yellow spheres.
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(n = 3), the cytoplasmic gate mutation M107A severely disrupts
transport activity (Table 1).
A cavity is present between the MetI subunits in the OWF
conformation (Fig. 5B), whose boundary is defined by residues
Y160 and F103 at the top and bottom of the cavity, respectively
(Fig. 7A), along the translocation pathway. This cavity is smaller
than those observed in the maltose and vitamin B12 transporters
(40, 42) (Fig. 5B) and could accommodate a methionine. No
binding of methionine was observed, however, in the trans-
location pathway of MetNIQ either in the original structure
determination or after soaking crystals in selenomethionine, or
as inferred biophysically by ITC measurements using the pre-
formed MetNIQ complex with N229A MetQ to bypass binding
of D-methionine to SBP MetQ. This is in contrast to the maltose
MalFGK2 and arginine ArtQN transporters where substrates are
found in the translocation pathway (40, 44, 45). Together with
the gating residues M163 and M107, Y160 and F103 residues
from both MetI subunits line the translocation pathway as if to
form a selectivity filter, M-Ω-Ω-M (Ω, aromatic ring residue),
for methionine selection (Fig. 7B). Aromatic rings from these
residues may favor a selection toward the sulfur atom of the
methionine residue, as seen in the binding pocket of holo-
MetQ (17).
A Noncanonical Transport Mechanism for D-Methionine
Detailed structural mechanisms have been developed for the
transport cycles of MalFGK2E by Chen and coworkers (22) and
BtuCDF by Locher and coworkers (23), reflecting a canonical
role for the SBP in delivering substrate to the transporter. Our
observations on the uptake of D-(seleno)methionine by MetNI
support the presence of a distinct (noncanonical) mechanism
where the initial substrate binding event is proposed to occur
directly to the MetNIQ complex. The noncanonical and canon-
ical models are compared in Fig. 8; a critical parameter dis-
tinguishing these pathways will be the affinity of the SBP for
substrate, with the noncanonical pathway preferentially utilized
by lower-affinity substrates such as D-(seleno)methionine and the
canonical pathway favored by higher-affinity substrates such as L-
methionine. Two intermediates are common to both pathways in
this scheme, the IWF MetNI state 1 and the OWFMetNIQ state
3 containing bound substrate. The transition between state 3 and
state 1 is accompanied by the translocation of substrate across
the membrane. The distinction between the two pathways is
provided by the precise sequence of events for the association of
MetQ and substrate with the transporter. In the noncanonical
pathway, unliganded MetQ associates with the ATP-bound form
of MetNI to form state 2, corresponding to the MetNIQ struc-
ture determined in this work. D-(seleno)methionine from outside
the cell then binds to generate the transport-competent state 3.
In contrast, the canonical pathway proceeds through the asso-
ciation of liganded MetQ to MetNI to generate state 2′, which
consequently contains both SBP and substrate. State 2′ has been
modeled after the pretranslocation (pre-T) state of the maltose
and molybdate transporters where binding of the liganded SBP
precedes binding of ATP (22, 25); state 3 is then formed upon
binding of ATP.
The regulation of the MetNI transport cycle through tran-
sinhibition arises from the binding of intracellular L-methionine
to the C2 domains, resulting in transport termination. As
established previously (38), the presence or absence of methio-
nine toggles between two conformational states related by a
register shift in the β-sheet hydrogen-bonding pattern at the di-
mer interface between C2 domains. In the transinhibited state 4,
L-methionine bound to one C2 domain hydrogen bonds with
N295 of the other (SI Appendix, Fig. S3A), helping stabilize a
hydrogen-bonding network including between the peptide NH
and CO groups of the two A299 residues on adjacent β strands.
Fig. 4. Conformational changes in MetQ creates substrate entry pathways
in MetNIQ. (A) Superposition of the substrate-bound (colored cyan) and
MetNI complexed MetQ (colored slate) shows a 24° twist between the two
lobes that potentially provides access to potential substrate entry pathways.
(B) Possible substrate entry pathways (shown in gray spheres) to the
MetNIQ assembly were calculated by CAVER 3.0.2 pymol plugin with
shell radii of 3 Å (43).
Fig. 5. Translocation pathways of different ABC importers. (A) Surface slab
views of the outward-facing conformations of three ABC importers, in-
cluding MetNIQ (this work), MalFGK2 (PDB ID code 2R6G), and BtuCDF (PDB
ID code 4FI3), reveal potential substrate-binding pockets (red box in B) with
different sizes and shapes in the translocation pathways. Although MetI
subunits form a small cavity, larger cavities are observed in the case of
maltose and vitamin B12 transporters. Only maltose (shown in ball-and-stick)
was structurally observed in the cavity. (B) Although a scoop loop was pro-
posed to facilitate substrate handoff between the maltose- and vitamin B12-
binding proteins with their transporters, no scoop loop is present in the
methionine transporter.
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In the absence of bound L-methionine (states 1–3), the β-sheet
hydrogen-bonding network between C2 domains shifts two resi-
dues, so that A299 is now paired with M301 (SI Appendix,
Fig. S3B). As discussed above, the two conformations of the
C2 domains are coupled to significant changes in the separation
between the catalytic H-motif residues H199 and ultimately be-
tween the NBDs (Fig. 3). Transinhibition consequently reflects the
increased distance between H199 residues in the presence of bound
methionine, thereby precluding formation of the catalytically com-
petent NBD dimer for ATP hydrolysis.
A Kinetic Transport Model for both High-Affinity and Low-
Affinity Substrates
The ability of SBPs to mediate substrate uptake through both
free (in the canonical model) and transporter-bound (in the
noncanonical model) forms may represent a strategy to transport
both high- and low-affinity substrates in physiologically relevant
concentration ranges. A basic kinetic model (Fig. 9A) capturing
these properties can be devised where the SBP (Q) can bind to
the transporter (E1) in either substrate-bound (Qm) or substrate-
free (Q) to form E2′Qm and E2Q, respectively. These complexes
can then convert into a transport-competent form E3Q•m by
isomerization (rate constant k1) and binding of substrate [rate
constant k2(m)], which after transport returns to the initial E1
state. An informative comparison can be made between the two
cases where the substrate can bind to EQ and when it cannot
(the noncanonical and canonical pathways, defined by k2 > 0 and
k2 = 0, respectively), using a typical substrate concentration of
10−5 M. For high-affinity substrates (Kd << 10
−5 M), there is
little difference between these models, but for weakly bound
substrates, the ability of E2Q to bind substrates allows transport
to occur under condition of high Kd where Qm and E2′Qm would
only be present at low concentrations (Fig. 9B). Although the
details will depend on the specific parameter values used, eval-
uation of Km as a function of Kd reveals that Km plateaus above a
threshold Kd in this model (Fig. 9C), so that transport can occur
at physiological concentrations even for substrates that are
weakly bound by the SBP. Together with reports from the
maltose and vitamin B12 uptake systems supporting the binding
of substrate by the SBP–transporter complex (28, 30), these
observations highlight an active role for both the SBP and
transporter in the establishing the specificity and affinity of
substrates that are imported by ABC transporters (33).
Materials and Methods
Cloning, Expression, and Purification. The metN and metI genes were ampli-
fied from E. coli K12 genomic DNA and cloned into a pET-modified dual
vector, under two T7 promoters (pTN2) with the N-terminal hexahistidine
tag sequence at the 5′ end ofmetN as described previously (8, 46). ThemetQ
gene encoding for a mature MetQ with no signal sequence was cloned into a
separate pET19b (+) plasmid with N-terminal decahistidine tag followed by
an enterokinase-cleavage site. All of the mutations, including E166Q, N295A
in MetN, and N229A in MetQ, were done by site-directed mutagenesis
(Stratagene). The cloned plasmids were expressed separately in E. coli BL21-
gold (DE3) cells (EMD) at room temperature in ZY media (47).
Purification of MetNI mutants was carried out by homogenizing 10 g cell
paste in 100 mL of lysis buffer containing 20 mM Tris·HCl, pH 8, 100 mMNaCl,
10% glycerol, 5 mM β-mercaptoethanol (βMe), 20 μg/mL DNase I, 200 μg/mL
lysozyme. The cells were broken by three passes through a cell disruptor,
M110L pneumatic microfluidizer (Microfluidics). C12E7 was added at a final
concentration of 0.5% (vol/vol) to solubilize membranes at 4 °C for 2 h.
Unlysed cells and cell debris were removed by centrifugation at 100,000 × g,
4 °C, and 30 min. The supernatant was collected, 70 mM imidazole, pH 8.0,
was added, and the sample was then loaded onto a 5-mL Ni-Sepharose HP
column (GE Healthcare) equilibrated with the MetNI purification buffer
containing 20 mM Tris·HCl, pH 7.5, 100 mM NaCl, 0.1% C12E7, 70 mM imid-
azole. After sample loading, the column was washed with 12 column vol-
umes of the purification buffer. Two column volumes of elution buffer
containing 20 mM Tris·HCl, pH 7.5, 100 mM NaCl, 0.1% C12E7, 300 mM im-
idazole were used to elute protein off the Ni column. The eluate was then
subjected to size-exclusion chromatography. The eluted peaks were col-
lected, concentrated, ultracentrifuged (267,000 × g, 20 min, 4 °C) to remove
aggregation, and adjusted to 12 mg/mL. Three hundred-μL-per-tube aliquots
of MetNI were flash frozen in liquid nitrogen and stored at −80 °C.
Purification of signal sequence cleaved MetQ was done by resuspending
10 g cell paste in 100mL of lysis buffer asmentioned above. Cell lysis was done
by freezing and thawing for three cycles in liquid nitrogen and in a 42 °C
water bath, respectively. Clearing of cell lysates was done by centrifugation
at 37,500 × g, 30 min, and 4 °C. After the supernatant was collected, 70 mM
Fig. 6. Conformational changes of the translocation pathway gates of the
MetNIQ complex. Structure comparison of the MetI subunits in their
outward-facing conformation (A and C) (colored forest and pale yellow)
versus inward-facing conformation (B and D) (colored gray) reveals major
rearrangements of the periplasmic gate residues, including Y177 and M163
(cyan; shown in ball-and-stick representation) (A and B), and of the cyto-
plasmic gate residues, including F103, M107, and Y160 (black; shown in ball-
and-stick representation) (C and D).
Fig. 7. Residue rearrangement and potential substrate-binding cavity along
the translocation pathway. (A) Movement of TM3 and TM4 of the MetI
subunits form a small cavity (shown in Fig. 5A), whose boundary is defined
by residues Y160 and F103 along the translocation pathway. (B) Superposi-
tion of MetI subunits in the OWF and IWF conformation reveals a rear-
rangement of a potential selectivity filter, M-Ω-Ω-M (Ω, aromatic ring
residues), along the translocation pathway of the OWF MetNIQ. Side chains
in the OWF and IWF conformations are colored cyan and black, respectively.
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imidazole, pH 8.0, was added before loading onto a 5-mL Ni-Sepharose HP col-
umn (GE Healthcare) equilibrated with purification buffer containing 20 mM Tris·
HCl, pH 7.5, 100 mM NaCl, 70 mM midazole. After sample loading, the column
was washed with 12 column volumes of the same buffer. Two column volumes of
elution buffer containing 20 mM Tris·HCl, pH 7.5, 100 mM NaCl, 300 mM imid-
azole were used to elute protein off the Ni column. The eluate was then subjected
to size-exclusion chromatography. The eluted peaks were pooled, incubated
with enterokinase (NEB) to cleave the His tag, and passed through a hand-
packed Ni column again to remove uncut MetQ. The His-tag–cleavedMetQ was
then concentrated to 20 mg/mL and flash-frozen in aliquots of 300 μL per tube.
Selenomethionine-Substituted Proteins. To prepare selenomethionine-substituted
MetNI and MetQ proteins, the cloned plasmids were transformed in E. coli
auxotroph B834 (DE3) cells (EMD), which were then grown in phosphate-,
amino acids-, and selenomethionine (PASM)-containing autoinduction
media (47), containing 125 μg/mL selenomethionine for 3–5 d at room
temperature.
Crystallization of the E. coli MetNIQ Protein Complex. The native MetNIQ and
selenomethionine-substituted MetNIQ complexes were prepared as de-
scribed previously (17). Crystallization screens for MetNIQ were conducted at
different concentrations, 5–20 mg/mL, by vapor diffusion in hanging
drops at 20 °C using three different commercial kits, including Mem-
Gold2, MORPHEUS (Molecular Dimension), and PEGRx (Hampton Re-
search). MetNIQ was crystallized in a reservoir containing 0.1 M Mes, pH 6,
and 22% PEG 400, using 5 mg/mL protein at a ratio of protein to reservoir of
2:1. Crystals appeared after 2–3 d, fully grew after 5–7 d, and shattered after
10–14 d. Crystals were harvested at day 7 and cryoprotected by increasing
PEG 400 concentration to 25, 30, and then 35%, followed by flash-freezing
for data collection. Selenomethionine-substituted MetNIQ crystals often
diffracted better than the native ones.
Heavy-Metal Derivatives.MetNIQ crystals were soaked in crystallization buffer
(0.1 M Mes, pH 6, and 22% PEG 400) containing 1 mM K2HgI4 for an hour
before back-soaking, cryoprotecting, and flash-freezing.
Data Collection and Structure Determination. All X-ray diffraction datasets
were collected at the Stanford Synchrotron Radiation Laboratory (SSRL)
beamline 12-2 equipped with a PILATUS 6M pixel array detector. Diffraction
Fig. 8. Mechanistic model for the MetNI-catalyzed transport of methionine derivatives. The relationship between the canonical and noncanonical pathways
in the MetNI transport cycle is illustrated utilizing available structures of MetNI, MetQ, and MetNIQ represented as cylinders. Methionine, ADP, and ATP are
shown as ball-and-sticks. Conformational states of the two C2 domains are shown in cyan and firebrick colored surface representations. State 1 represents a
resting state of MetNI (PDB ID code 3TUJ). In the noncanonical pathway, state 2 represents an ATP-bound MetNIQ in the absence of methionine (this study;
PDB ID code 6CVL). D-methionine can subsequently access the translocation pathway of the MetNIQ assembly through MetQ to form state 3 (also modeled as
PDB ID code 6CVL). The canonical pathway proceeds through state 2′ depicted as a hypothetical pre-T conformation of L-methionine–bound IWF MetNIQ,
based on structural studies of the maltose and molybdate transporters (22, 25). The transition from state 3 to state 1 is common to both pathways and
associated with methionine transport into the cell. During the transport cycle, the C2 domains are in unlocked conformations that can accommodate the
changes between IWF and OWF states. State 4 represents the transinhibited state of MetNI transporter (PDB ID code 3TUZ) with the C2 domains in a locked
conformation stabilized by methionine binding and rearrangement of the β-sheet hydrogen bonding pattern at the interface between the C2 domains.
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images were processed and scaled with X-ray Detector Software (XDS) (SI
Appendix, Table S1).
Several datasets diffracting anisotropically to 4–3 Å resolution were col-
lected at wavelengths of 1.0000 Å (native crystals), 0.9794 Å (Semet-
substituted crystals), and 1.00582 Å (Hg-soaked crystals). Ellipsoidal trunca-
tion and anisotropic scaling were applied to the MetNIQ diffraction datasets
using the University of California, Los Angeles, Molecular Biology Institute
Diffraction Anisotropy server (services.mbi.ucla.edu/anisoscale) (48) (SI Ap-
pendix, Fig. S4). All crystals belonged to space group P3221 and showed
partial twinning with twinning fractions ranging from 0.10 to 0.28 de-
termined by Xtriage (Phenix) (49); therefore, a twin law with operator -h, -k,
l was applied. Initial phases were obtained by molecular replacement–single
anomalous dispersion (SAD) (AutoSol, Phenix) using SAD data from a 3.8-Å
selenomethionine derivative crystal and a MalFGK2-E (PDB ID code 2R6H)–
derived model of MetNI in an OWF conformation as a partial model. SAD
experimental phasing (Phaser-EP; Phenix) using heavy-atom (selenium) sites
was carried out to reduce model bias (SI Appendix, Fig. S5). These phases
were extended to 3.5 Å resolution and then 2.95 Å resolution using two
other higher-resolution datasets, the latter collected from a K2HgI4-soaked
crystal. Coupled with density modifications (AutoSol; Phenix), the latter
showed clear electron densities for MetQ, which allowed us to manually
dock the two individual lobes of MetQ. Validation of the sequence register
was obtained from the selenium positions and the location of mercury sites
near cysteines in MetN observed from a K2HgI4-soaked MetNIQ crystal. The
MetNIQ model was refined using a combination of Phenix.refine (49), phe-
nix.rosetta_refine (50), and Refmac5 (Collaborative Computation Project
Number 4) (51). Although the densities of MetN and MetI subunits are well
defined, that of MetQ is weaker (SI Appendix, Fig. S6). The absence of crystal
contact in the MetQ of the MetNIQ crystal may result in some flexibility or
even some orientational disorder. In general, the final model of MetNIQ fit
the density calculated from the 2.95-Å resolution dataset well, and the final
Rwork/Rfree = 0.21/0.23 (refinement statistics are in SI Appendix, Table S1).
Software used in the project was installed and configured by SBGrid (52).
Structure Comparisons. The OWF conformation of MetNI determined in this
work (PDB ID code 6CVL) was compared with IWF conformations determined
previously (8, 38): unlocked C2 domains in the presence of the detergent
n-decyl-β-D-maltoside (DM; PDB ID code 3TUJ) and locked C2 domains in the
presence of the detergent cyclohexyl-pentyl-β-D-maltoside (CY5; PDB ID
code 3TUI) and with bound selenomethionine (PDB ID code 3TUZ). The
structure of methionine-bound MetQ (PDB ID code 4YAH) is described in
Nguyen et al. (17).
In Vivo Transport Assays.Whole-cell uptake assays were conducted following
an established protocol by the Poolman laboratory (24). In brief, different
arabinose-inducible (pBAD) plasmids that carry variants of metN, metI, and
metQ genes were transformed into ΔmetNIQ E. coli strain BW2115. Cells
were grown in LB media to an OD600 of 1.5, induced for 2 h with 0.2%
arabinose, and harvested by centrifuging for 10 min at 5,000 × g, 4 °C. The
cell pellets were then washed twice in 50 mM sodium phosphate buffer,
pH 6.5, and resuspended to OD600 ∼ 10 in the same buffer. Before transport
assays, cells were energized with 0.5% glucose and 5 mM MgCl2 for 10 min
at 37 °C. The transport assays were started by adding D-selenomethionine (D-
semet) at different concentrations at 37 °C, shaking at 300 rpm. The reac-
tions were then stopped by centrifugation at 18,000 × g, 4 °C, for 1 min,
followed by discarding the supernatant. The pellet was washed three more
times in the same buffer before homogenizing in 20% HNO3. The samples
were incubated at 85 °C overnight and diluted 10-fold for quantifying se-
lenium content by ICP-MS (8800 QqQ; Agilent) [Environmental Analysis
Center, California Institute of Technology (Caltech)]. The amount of MetNI
and MetQ in each reaction was quantified by Western blot using an anti-His
antibody against His-tagged MetN and MetQ, respectively. A correlation
between different substrate concentrations and uptake rate was shown in a
final Michaelis–Menten plot (Fig. 1B) and a summary table (Table 1). Data
were processed using SigmaPlot 10.0 (SigmaPlot).
Isothermal Titration Calorimetry. MetQ variants were dialyzed overnight in
their purification buffers using a Slide-a-lyser mini dialysis device (Thermo
Scientific). The samples were then ultracentrifuged at 267,000 × g, 4 °C, for
20 min to remove aggregates and the protein concentration adjusted
to 100 μM. Substrate D-methionine was prepared in the last dialysis buffer
of each sample. Titrations of D-methionine to MetQ variants were done in
triplicate on a MicroCal iTC-200 calorimeter at 25 °C. Titration curves were
shown in SI Appendix, Fig. S1. Data were processed using Origin v7.0
(OriginLab).
Steady-State Rate Solution to Kinetic Scheme in Fig. 9. E1, E2Q, E2′Qm, Q, and
Qm are assumed to be in equilibrium with dissociation constants defined in
Fig. 9A. The total SBP concentration, Qtot = (Q) + (Qm), is assumed to be
Fig. 9. Kinetic analysis of canonical and noncanonical substrate uptake by ABC transporters. (A) Kinetic scheme modeling canonical and noncanonical
pathways in substrate import by the transporter, E, where E1, E2, E2′, and E3 represent different states of the transporter as shown in Fig. 8. The methionine
ligand (m) binds to Q to form the liganded species Qm with a dissociation constant Kd. Qm and Q can bind to E1 to form E2′Qm and E2Q, with effective
dissociation constants K1 and K2, respectively. Transport occurs from the state E3Q•m that is generated either by isomerization of E2′Qm with the first-order
rate constant k1 or by binding of m to E2Q with a second-order rate constant k2. The steady-state solution to this scheme for the case where E, E2′Qm, E2Q, Q,
and Qm are at equilibrium is described in Materials and Methods. (B) Dependence of the transport rate for a substrate at 10 μM concentration on vari-
ous parameters of the kinetic scheme in A, as a function of the Kd for binding of substrate to the SBP. Curves i, ii, and iii correspond to k2 = 5,000, 500, and
0 M−1·s−1, with Qtot = 10
−4 M, K1 = K2 = 10
−4 M, and k = k1 = 0.01 s
−1. For substrates with high affinity to the SBP (Kd < ∼10−6 M) the models are equivalent,
whereas for more weakly bound substrates (Kd > ∼10−4 M) the transport rate depends critically on the value of k2. Depending on the value of k2, the rate of
transport of a weakly bound substrate can exceed that of a substrate that binds tightly to the SBP (compare curves i and ii). When k2 = 0 (curve iii), transport
does not occur under these conditions, which corresponds to the case where substrate is only delivered to E1 by binding to the SBP. (C) Dependence of the Km
for transport on the dissociation constant Kd for binding of substrate to the SBP. The red and black circles represent experimental data points for the me-
thionine (this study) and maltose transporter (30), respectively. The curves are generated with the following parameters: i, k = 0.01 s−1, k1 = 0.1 s
−1, and k2 =
1,000 M−1·s−1; ii, k = 0.1 s−1, k1 = 0.1 s
−1, and k2 = 100 M
−1·s−1; and iii, k = 0.1 s−1, k1 = 0.1 s
−1, and k2 = 0 M
−1·s−1, with Qtot = 10
−4 M and K1 = K2 = 10
−4 M for all
curves. Curves were not explicitly fit to the experimental data but reflect parameter values that approximate the data. For this kinetic scheme, Km reaches a
plateau as Kd increases, and depending on the parameter values, this plateau can be tuned to the physiological concentration range. For curve iii, where substrate
does not bind to E2Q, a plateau region is not reached, so substrates with poor affinities for Q (high Kd) would have correspondingly high Km values.
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much larger than the total transporter concentration, Etot = (E1) + (E2Q) +
(E2′Qm) + (E3Q•m), and so the contributions of (E2Q), (E2′Qm), and (E3Q•m) to
Qtot are neglected.
The concentrations of (E3Q•m) and (X) = (E1) + (E2Q) + (E2′Qm) may be
determined using the steady-state treatment detailed in Segel (53) and Cha
(54), yielding
Etot = ðE1Þ + ðE2QÞ + ðE2′QmÞ + ðE3Q•mÞ
∝ fkðK1K2ðKd + ðmÞÞÞg+ fkK1KdQtotg+ fkK2QtotðmÞg
+ fðk1K2 + k2K1KdÞQtotðmÞg.
The rate of transport [v = k(E3Q•m)] relative to the maximum possible rate
(V° = kEtot) is
v
Vo
≡
kðE3Q•mÞ
kEtot
=
ðk1K2+k2K1KdÞQtotðmÞ
fkðK1K2ðKd + ðmÞÞÞg+ fkK1KdQtotg+ fkK2QtotðmÞg+ fðk1K2+k2K1KdÞQtotðmÞg.
Putting this into standard form allows the evaluation of Vmax and Km (Vmax in
this context represents the fraction of the maximum possible rate V° ):
v
Vo
≡
VmaxðmÞ
Km + ðmÞ
⇒Vmax =
ðk1K2 + k2K1KdÞQtot
ðk1K2 + k2K1KdÞQtot + kK2ðK1 +QtotÞ
⇒Km =
kK1KdðK2 +QtotÞ
k  K1K2 + k  K2Qtot + k1K2Qtot + k2K1KdQtot
.
In the limits as Kd → 0 and Kd → ∞, the values of Km approach
Kd→ 0, Km→
k  K1ðK2 +QtotÞ
k  K1K2 + k  K2Qtot + k1K2Qtot
Kd
Kd→∞,  Km→
k  ðK2 +QtotÞ
k2Qtot
,
so that for high-affinity substrates (Kd → 0), Km ∝ Kd, and for low-affinity
substrates, Km plateaus to a constant value.
This scheme focuses on the interactions of the transporter, SBP, and ligand
m and omits many features of the transport cycle, including the binding of
ATP, ATP hydrolysis, and dissociation of the products ADP and Pi, and the
interconversion of inward- and outward-facing conformations. Because there
is a strong nucleotide state dependence to SBP binding, the dissociation
constants in scheme Fig. 9A have been approximated as effective dissocia-
tion constants described by the ratio of the dissociation rate constants for
E2Q or E2′Qm and the association rate constant between E1 and Q or be-
tween E1 and Qm. For MetNIQ, the association rate constant is ∼103 M−1·s−1,
independent of whether MetQ has bound methionine or not and in-
dependent of whether MetNI is in the ATP or nucleotide free states (29, 55).
Under turnover conditions, dissociation of the complex will be set by the
rate of ATP hydrolysis, which has been measured to be ∼25 min−1 or ∼0.3 s−1
(39) so that as an order of magnitude estimate, K1 ∼ K2 ∼ 10−4 M−1. For
comparison, the dissociation constants for the binding of unliganded and
liganded MetQ to the ATP-bound form of MetNI are 27 nM and 1 μM (17),
respectively, when ATP hydrolysis is prevented through either mutation or
absence of Mg+2. The calculations for Fig. 9 were performed with Mathe-
matica version 9.0.0.0.
The transport rate determined for the N295A MetNI transporter with D-
selenomethionine [∼10 nmol·min−1·mg−1 (Table 1)] is equivalent to a turn-
over time of ∼0.02 s−1, which provides an estimate for the rate constant k;
this rate is consistent with measurements made on other ABC transporters,
with turnover times of ∼0.002–0.03 s−1 (24, 26, 56–58).
Data and Materials Availability. Coordinates and structure factors have
been deposited in the Protein Data Bank of the Research Collaboratory
for Structural Bioinformatics, with PDB ID code 6CVL. The MetNI and
MetQ constructs have been deposited with Addgene, with IDs 118269
(N295A E166Q MetNI) and 118268 (N229A MetQ) for the structural work,
and IDs 118253, 118254, 118256–118261 and 118581 for the transport
assay (Table 1).
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